Drug Approval | April 15, 2026
CDSCO invites bids for next-gen Digital Drugs Regulatory System
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
AI-enabled women’s digital clinic brings in-person consultations to complement app-led care after serving over 400,000 women across India
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
Paves the way for next-gen ultra-precise gas sensing
A major push to sharpen the future of cancer treatment is underway
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
BioNTech will supply pumitamig, a PD-L1/VEGF-A bispecific antibody co-developed with Bristol Myers Squibb, while Boehringer Ingelheim will act as the regulatory sponsor of a Phase Ib/II study
Subscribe To Our Newsletter & Stay Updated
